Company intelligence / Profile preview
Beijing KBD Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Beijing KBD Pharmaceutical, also known as Beijing Kangbeide Pharmaceutical, is a China-based pharmaceutical company specializing in the research, development, and manufacturing of psychiatric and neurological medications. The company operates a large-scale production facility in Beijing that is compliant with Good Manufacturing Practice (GMP) standards. Its product portfolio primarily focuses on treatments for schizophrenia, depression, and sleep disorders, offering a range of generic and branded small molecule therapeutics. KBD Pharmaceutical serves as a key supplier in the Chinese domestic market for central nervous system (CNS) drugs.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Beijing KBD Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing KBD Pharmaceutical.